Showing results (161-170 of 167) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Journal of Medicinal Chemistry|May 26, 2007
Syntheses of potent, selective, and orally bioavailable indazole-pyridine series of protein kinase B/Akt inhibitors with reduced hypotensionGui-Dong Zhu, Viraj B Gandhi, Jianchun Gong, et al.Anti-Cancer Drugs|October 14, 2005
A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studiesWen-Zhen Gu, Ingrid Joseph, Yi-Chun Wang, et al.Communications Chemistry|August 16, 2024
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complexQi Hao, Manoj K Rathinaswamy, Kelly L Klinge, et al.Journal of Medicinal Chemistry|September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitorsYujia Dai, Yan Guo, Robin R Frey, et al.Journal of Medicinal Chemistry|December 30, 2020
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug DesignJustin D Dietrich, Kenton L Longenecker, Noel S Wilson, et al.Journal of Medicinal Chemistry|March 9, 2007
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitorYujia Dai, Kresna Hartandi, Zhiqin Ji, et al.Molecular Cancer Therapeutics|June 16, 2005
Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivoYan Luo, Alexander R Shoemaker, Xuesong Liu, et al.Pageof 17